HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy

Heart Congress 2025

Thomas Bernd Dschietzig, Speaker at Heart Conference
Keynote Presentation (In-Person)
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany

Human relaxin-2 (hRlx-2) is a hormone of pregnancy that has engendered a great deal of interest as a therapy for various cardiovascular and inflammatory diseases, among them Acute Heart Failure and Systemic Scleroderma. Here, we propose and summarize data showing that Rlx-2 repre [....] » Read More

Narendra Kumar, Speaker at Heart Congress
Keynote Presentation (In-Person)
Narendra Kumar, HeartbeatsZ Academy, United Kingdom

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While catheter ablation is a well-established treatment for AF, it carries risks of complications such as pulmonary vein stenosis (PVS) and esophageal injury. Pulse field ablation (PF [....] » Read More

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary arterial hypertension (PAH) remains a debilitating disease with high morbidity and mortality. It is a rare, progressive and ultimately life-threatening disease in which blood vessels in the lungs thicken and narrow, causing significant strain on the heart. Patients with [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the recogni [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Thomas J Webster, Hebei University of Technology, China

Nanomedicine, or the use of materials with at least one dimension less than 100 nm, has led to improved disease prevention, diagnosis, and treatment. This talk will cover recent advances in the use of nanomaterials to prevent, diagnose, and treat cardiovascular diseases. Specific [....] » Read More

Michael R Mantell, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Michael R Mantell, University of Pennsylvania, United States

Physicians are increasingly faced with the dual burden of delivering exceptional care while navigating the pressures of high-stakes environments. These challenges, compounded by long hours, emotional demands, and administrative responsibilities, have led to a crisis in physician [....] » Read More

Desislava Doycheva, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Desislava Doycheva, Loma Linda University, United States

Cardiovascular diseases, particularly myocardial infarction (MI), remain a major global health challenge. Recent studies have highlighted the cardioprotective potential of sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally developed for managing glycemia in diabetes. [....] » Read More

Ravi Kanagala, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Ravi Kanagala, LCMC Health, United States

The use of biologics in sternal closures is underexplored, previous studies suggest biologic augmentation can enhance patient outcomes. This study evaluated the biomechanical performance of two sternal closure techniques; stainless steel wire and titanium plate fixation under var [....] » Read More

Angela Maria Torres Torres, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Angela Maria Torres Torres, Marshall University, United States

Background: Quadricuspid aortic valve is a rare congenital cardiac defect with estimated incidence rate of 0.013%. Historically, encountered during open heart surgery or postmortem. Currently diagnosed primarily via transechocardiography. The etiology hypothesis involves the part [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom

Effective communication is at the heart of quality patient care, especially in cardiology, where complex medical decisions can significantly impact patient outcomes. This speech addresses the critical role of communication between cardiologists and patients in enhancing cardiac c [....] » Read More

Claudio Soto, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Claudio Soto, St Vincent's Hospital, Australia

The use of donation after circulatory death (DCD) donors for heart transplantation represents a relatively new entry into efforts made to help expand the donor pool. The use of Normothermic Machine Perfusion (NMP) through the Transmedics Organ Care System Heart (OCS Heart) allows [....] » Read More

Katherine Carleton Eagleton, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Katherine Carleton Eagleton, University of Canberra, Australia

In Australia, the self-management of heart failure in the patient’s home is recommended by Clinical Guidelines to decrease (re)hospitalisation and mortality and should actively include both the patient and their caregiver. However, there is an expectation that as part of th [....] » Read More

Alexander Filippov, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Alexander Filippov, St. Petersburg State University, Russian Federation

Background: Smoking status (SS) is associated with structural and functional vascular changes which may lead to increased arterial stiffness and, as a consequence, the formation of early vascular aging. The purpose of this study was to investigate the relationship between th [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibiting [....] » Read More

Hui Geng, Speaker at Heart Conferences
Oral Presentation (In-Person)
Hui Geng, Peking University First Hospital, China

Classic Orthostatic Hypotension (OH) is a common geriatric disorder and is associated with cardiovascular risk. There are so far too few data available on the prognostic importance of initial OH and the comparison with sustained OH. This study investigated cardiovascular outcomes [....] » Read More

Zhang Xin, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Zhang Xin, Capital Medical University, China

Aim: Atrial septal defect (ASD) is a typical cardiac defect in the atrial septum, which accounts for around 10% of congenital heart disease (CHD). The early diagnosis and treatment of ASD are crucial to avoid serious complications. Conventional pre-treatment assessment methods to [....] » Read More

Fangyun Wang, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Fangyun Wang, Capital Medical University, China

Introduction: Double-chambered left ventricle (DCLV) is a particularly rare congenital cardiovascular malformation that is difficult to diagnose. It is characterized by the subdivision of the left ventricle into two chambers by an abnormal septum or muscle band. Compared to [....] » Read More

Nidhish Niranjan Nisty, Speaker at Heart Conferences
Oral Presentation (In-Person)
Nidhish Niranjan Nisty, Nisty Heart Centre, India

Introduction: The coronary slow flow phenomenon is an important, angiographic entity characterized by delayed progression of the injected contrast medium through the coronary tree. The clinical implications are significant, with over 80% of patients experiencing recurrent chest p [....] » Read More

T Rajini Samuel, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
T Rajini Samuel, Shri Sathya Sai Medical College and Research Institute, India

Introduction: Electrocardiogram (ECG) interpretation plays an immense clinical role for the diagnosis of coronary heart disease. But its interpretation remains a challenging task for junior medical staffs. Einthoven applied vectors to discuss the cardiac electrical activity even [....] » Read More

Muhammad Wasim Sajjad, Speaker at Heart Conferences
Oral Presentation (In-Person)
Muhammad Wasim Sajjad, Rehman Medical Institute, Pakistan

Introduction: To compare autologous versus non-autologous transfusion in patients undergoing CABG and its early outcomes. This study seeks to evaluate the impact of different transfusion strategies on key postoperative outcomes, including morbidity and mortality. Methodology: [....] » Read More

Omaima Taie, Speaker at Heart Conferences
Oral Presentation (In-Person)
Omaima Taie, Mohammed V University, Morocco

Tumor-like calcinosis is a condition where calcium phosphate crystals accumulate in the tissues around joints, forming large, calcified masses. Although the exact mechanisms are not fully understood, it is believed that an elevated calcium-phosphate product and severe hyperparath [....] » Read More

Omaima Taie, Speaker at Heart Conferences
Oral Presentation (In-Person)
Omaima Taie, Mohammed V University, Morocco

Background: Peripheral artery disease (PAD) is often linked to heart failure with preserved ejection fraction (HFpEF), a condition characterized by impaired left ventricular (LV) relaxation during diastole. LV diastolic dysfunction is a critical component of HFpEF. This investiga [....] » Read More

Ali Mohammadpour, Speaker at Heart Conferences
Oral Presentation (In-Person)
Ali Mohammadpour, Gonabad University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Chest pain is a common complaint in patients with acute coronary syndrome(ACS). Pharmacological pain management is associated with different side effects. This study aimed to determine the effect of local heat therapy on the chest pain in patients with ACS. [....] » Read More

Shibikom Tamirat, Speaker at Heart Conferences
Oral Presentation (In-Person)
Shibikom Tamirat, Childrens’ Heart Fund of Ethiopia, Ethiopia

With the advent of interventional cardiology service in Ethiopia, there is increasing number of pacemaker pocket infection. In principle, pacemaker pocket infection shoud be managed with explantation of the generator and the leads as well. Then the patient will be kept on tempora [....] » Read More

Vijay Suryakant Kapse, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Vijay Suryakant Kapse, Kasturba Medical College, India

Cardiovascular diseases (CVDs) account for nearly 18 million deaths annually, placing a significant burden on global healthcare systems, particularly in underrepresented regions. Early risk prediction remains critical for timely interventions and improved patient outcomes. This s [....] » Read More

Ali Hassan, Speaker at Cardiovascular Diseases Events
Poster Presentation (In-Person)
Ali Hassan, King's College London, United Kingdom

Introduction: Platelet Endothelial Cell Adhesion Molecule (PECAM-1) is a transmembrane glycoprotein crucial for vascular endothelial cell (VEC) differentiation from precursor cells. Monitoring PECAM-1 expression within human induced pluripotent stem cell (hiPSC) models is essenti [....] » Read More

Getu Debalkie Demissie, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Getu Debalkie Demissie, Baker Heart and Diabetes Institute and La Trobe University, Australia

Background: Studies have demonstrated the short-term effectiveness of structured lifestyle interventions in lowering absolute cardiovascular disease (CVD) risk among individuals at high risk for type 2 diabetes. However, their long-term impact remains unclear. Objective: This [....] » Read More

Abderrahim Oulhaj, Speaker at Heart Conferences
Poster Presentation (In-Person)
Abderrahim Oulhaj, Khalifa University, United Arab Emirates

Background: There has been a growing interest in investigating the association between visit-to-visit variability in established risk factors and the incidence of cardiovascular disease (CVD). Some research has demonstrated that larger within-patient variability in certain e [....] » Read More

Yoandy Lopez de la Cruz, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Yoandy Lopez de la Cruz, Ministry of Public Health, Cuba

Internal thoracic artery (ITA) harvesting is an important surgical procedure in cardiovascular surgery. In recent decades, more and more patients are revascularized with grafts from both internal thoracic arteries, which has shown better long-term outcomes. Since Favaloro introdu [....] » Read More

Runze Wen, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Runze Wen, The First Affiliated Hospital of USTC, China

Background: Ischemia with no obstructive coronary arteries (INOCA), a chronic disorder with a poor prognosis, remains diagnostically challenging. Positron emission tomography (PET) has been established as the non-invasive reference benchmark for quantifying myocardial blood flow [....] » Read More

Vivek Vaibhav, Speaker at Cardiovascular Diseases Events
Poster Presentation (In-Person)
Vivek Vaibhav, Rama Medical college Hospital and Research Center, India

A 77-year-old Female  patient underwent an open thoracotomy for lung B/L breast cancer. Preoperative PVB was performed at the T5-T7 levels, using a combination of liposomal bupivacaine and standard bupivacaine for both intraoperative anesthesia and postoperative pain relief. [....] » Read More

Sandra Lungu, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Sandra Lungu, Lusaka Apex Medical University, Zambia

Iron plays a key role in oxygen uptake, transport, storage, and oxidative metabolism in the muscle including myocardium. Iron deficiency (ID) in chronic heart failure (CHF) patients has a mortality of 35% is reported at the university teaching hospital (UTH). Information on ID in [....] » Read More

Abdul Rahman Elhassan, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Abdul Rahman Elhassan, National University, Sudan

Constrictive pericarditis is an uncommon but serious complication of lung transplantation, marked by pericardial fibrosis and impaired diastolic filling. It can lead to significant morbidity if not recognized and treated early. This case highlights a rare instance of constrictive [....] » Read More

Shuping Zhong, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Shuping Zhong, University of Southern California, United States

Myocardial hypertrophy manifests magnification of cardiomyocyte volume rather than number increasing in the adult heart. The differentiation of cardiomyocytes shortly terminates after birth. The cardiomyocytes no longer proliferate like other tissue cells. Myocardial hypertrophy [....] » Read More

Federico Benetti, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Federico Benetti, Benetti Foundation, Argentina

Direct myocardial transplantation of HFDSCs (Fetal Liver Stem Cells) by open-chest surgical procedure was performed in 10 patients with HF due to nonischemic, nonchagasic dilated cardiomyopathy. All 10 patients survived the operation. At 40 months, the mean (+/-SD) NYHA class dec [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Lipoprotein (a) [Lp(a)] is a unique lipoprotein particle composed of an LDL-like particle linked to a glycoprotein called apolipoprotein(a). Elevated levels of Lp(a) have been identified as an independent risk factor for cardiovascular disease, including atherosclerosis, heart at [....] » Read More

Esther M Weiss, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Esther M Weiss, Advocate Sherman Hospital, United States

The APN functions as the patient advocate, the care facilitator and the optimizer of the patient’s hospital journey and experience. Areas of practice: Advanced knowledge and experience in the management of implanted cardiac devices, optimizing their function, enabl [....] » Read More

Abhishek Chandra, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Abhishek Chandra, Abbott Northwestern Hospital, United States

Background: Direct-acting oral anticoagulants (DOACs) are absorbed in the upper gastrointestinal tract, but patients with gastrointestinal disease were not included in the Phase II and III drug investigations. This report details a patient with altered gastrointestinal anatomy an [....] » Read More

Tahmineh Azizi, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Tahmineh Azizi, Florida State University, United States

Kinetic modeling is an essential method in understanding the dynamic interactions of biological systems, particularly in the context of cardiovascular physiology. This study delves into the application of kinetic modeling to elucidate the heart's function as a critical input [....] » Read More

Maria Borrell, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Maria Borrell, Sant Pau Research Institute, Spain

Although the regulation of cholesterol homeostasis in the body has been extensively studied, there is little information on how this regulation takes place in the brain. Cholesterol does not cross the blood-brain barrier; therefore cholesterol metabolism in the brain is independe [....] » Read More

Joao Rafael Rocha Da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael Rocha Da Silva, Connect Life Rehabilitation And Performance, Brazil

Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis. In previous studies, we observed that it directly impacts cardiac rehab [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Heart Conferences
Oral Presentation (Virtual)
Cristina Milagre Quadros Borges, Hcor- Heart Hospital of Sao Paulo, Brazil

Cardiovascular diseases (CVD) correspond to the main cause of death worldwide in both sexes. 1/3 of deaths from all causes affects men and women in all age groups. They represent more than bouble the number of deaths from all neoplas associated. Increase in the prevalence of CVD [....] » Read More

Narayanan Gokarneshan, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Narayanan Gokarneshan, SSM College of Engineering, India

Composite textile stents with core-shell structure have been developed. Biodegradable polyvinyl alcohol (PVA) yarns are twisted and then coated with polycaprolactone/polyethylene glycol (PEG) blends. The coated yarns are weft knitted into braids and then thermally treated to form [....] » Read More

Nilay Solanki, Speaker at Charotar University of Science and Technology
Oral Presentation (Virtual)
Nilay Solanki, Charotar University of Science and Technology, India

Background: Coronary artery disease (CAD) results from the obstruction of blood supply to the heart. Angioplasty is a common intervention for managing CAD, supplemented by supportive and preventive therapies. Modifiable risk factors for CAD include hypertension, diabetes, dy [....] » Read More

Geeta Deswal, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Geeta Deswal, Guru Gobind Singh College of Pharmacy, India

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide. Modern pharmacology offers a variety of treatments, yet the rising prevalence of CVDs necessitates alternative and complementary strategies. Nature, with its vast repository of medicinal pl [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Introduction: Atrial fibrillation (AF) is one of the most common and probable serious arrhythmia and a hallmark of an increasing risk of pathological thrombus formation. Interestingly, normal sinus rhythm (NSR) is the standard rhythm in a normal person. The sino-atrial node (SAN) [....] » Read More

Nikolaos Ziogas, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Nikolaos Ziogas, European University of Cyprus, Cyprus

Patent Foramen Ovale (PFO) is a common anatomical lesion occurring in 20-34% of the population, and it may be a cause for paradoxical embolism to the cerebral or coronary arteries causing stroke or myocardial ischemia. PFO management in patients with thrombophilia without prior c [....] » Read More

Bhavya Parikh, Speaker at Heart Conferences
Poster Presentation (Virtual)
Bhavya Parikh, North Shore-Long Island Jewish, United States

Streptococcus agalactiae, commonly known as Group B strep (GBS), is an uncommon pathogen in most adults and is typically only seen in pregnant women and neonates. Local and systemic complications from GBS typically have a high mortality rate, with infective endocarditis (IE) bein [....] » Read More

Bufan Zhang, Speaker at Heart Conferences
Poster Presentation (Virtual)
Bufan Zhang, Tianjin Medical University General Hospital, China

Objective: Aortic dissection is closely associated with inflammation. Currently, red blood cell distribution width (RDW) has been regarded as a novel inflammatory biomarker. The role of RDW on the prognosis of patients with Type A aortic dissection after surgery still remains unc [....] » Read More

Bufan Zhang, Speaker at Heart Conferences
Poster Presentation (Virtual)
Bufan Zhang, Tianjin Medical University General Hospital, China

Objective: Coronary artery bypass grafting (CABG) via sternotomy is the standard and conventional procedure for patients with multivessel coronary artery disease. Minimally invasive coronary artery bypass grafting (MICS CABG) via left thoracotomy has become an alternative procedu [....] » Read More

Will be updated soon......
Watsapp